nodes	percent_of_prediction	percent_of_DWPC	metapath
Nedocromil—CYSLTR2—respiratory system—obesity	0.0192	0.102	CbGeAlD
Nedocromil—FPR1—respiratory system—obesity	0.0172	0.0916	CbGeAlD
Nedocromil—CYSLTR2—cardiovascular system—obesity	0.0147	0.0779	CbGeAlD
Nedocromil—PTGDR—adipose tissue—obesity	0.011	0.0584	CbGeAlD
Nedocromil—FPR1—digestive system—obesity	0.011	0.0582	CbGeAlD
Nedocromil—PTGDR—digestive system—obesity	0.0104	0.055	CbGeAlD
Nedocromil—HSP90AA1—hindbrain—obesity	0.0102	0.0544	CbGeAlD
Nedocromil—HSP90AA1—gall bladder—obesity	0.0101	0.0537	CbGeAlD
Nedocromil—PTGDR—adrenal gland—obesity	0.00987	0.0524	CbGeAlD
Nedocromil—FPR1—endocrine gland—obesity	0.00906	0.0481	CbGeAlD
Nedocromil—CYSLTR1—respiratory system—obesity	0.00721	0.0383	CbGeAlD
Nedocromil—HSP90AA1—islet of Langerhans—obesity	0.00663	0.0352	CbGeAlD
Nedocromil—HSP90AA1—respiratory system—obesity	0.00626	0.0332	CbGeAlD
Nedocromil—Eye redness—Topiramate—obesity	0.00612	0.0214	CcSEcCtD
Nedocromil—HSP90AA1—adrenal cortex—obesity	0.00525	0.0279	CbGeAlD
Nedocromil—CYSLTR1—adipose tissue—obesity	0.00487	0.0259	CbGeAlD
Nedocromil—HSP90AA1—cardiovascular system—obesity	0.00479	0.0254	CbGeAlD
Nedocromil—CYSLTR1—adrenal gland—obesity	0.00437	0.0232	CbGeAlD
Nedocromil—HSP90AA1—pituitary gland—obesity	0.00424	0.0225	CbGeAlD
Nedocromil—HSP90AA1—adipose tissue—obesity	0.00423	0.0224	CbGeAlD
Nedocromil—HSP90AA1—digestive system—obesity	0.00398	0.0211	CbGeAlD
Nedocromil—HSP90AA1—adrenal gland—obesity	0.00379	0.0201	CbGeAlD
Nedocromil—CYSLTR1—endocrine gland—obesity	0.00379	0.0201	CbGeAlD
Nedocromil—HSP90AA1—endocrine gland—obesity	0.00329	0.0175	CbGeAlD
Nedocromil—Tremor—Methamphetamine—obesity	0.00322	0.0113	CcSEcCtD
Nedocromil—Otitis media—Sibutramine—obesity	0.00321	0.0112	CcSEcCtD
Nedocromil—Tremor—Benzphetamine—obesity	0.00311	0.0109	CcSEcCtD
Nedocromil—HSP90AA1—liver—obesity	0.00296	0.0157	CbGeAlD
Nedocromil—Ocular hyperaemia—Topiramate—obesity	0.00296	0.0103	CcSEcCtD
Nedocromil—Disorder sight—Topiramate—obesity	0.00292	0.0102	CcSEcCtD
Nedocromil—Rash erythematous—Bupropion—obesity	0.00285	0.00995	CcSEcCtD
Nedocromil—Tremor—Phendimetrazine—obesity	0.00283	0.0099	CcSEcCtD
Nedocromil—Feeling hot—Bupropion—obesity	0.00278	0.0097	CcSEcCtD
Nedocromil—Cough increased—Sibutramine—obesity	0.00273	0.00954	CcSEcCtD
Nedocromil—Pneumonia—Cimetidine—obesity	0.00263	0.0092	CcSEcCtD
Nedocromil—Dyspepsia—Methamphetamine—obesity	0.00247	0.00864	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Methamphetamine—obesity	0.00242	0.00847	CcSEcCtD
Nedocromil—Tremor—Phenylpropanolamine—obesity	0.00242	0.00846	CcSEcCtD
Nedocromil—Dyspepsia—Benzphetamine—obesity	0.00238	0.00833	CcSEcCtD
Nedocromil—Cough increased—Bupropion—obesity	0.00238	0.00832	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Benzphetamine—obesity	0.00234	0.00817	CcSEcCtD
Nedocromil—Tremor—Phentermine—obesity	0.00232	0.00809	CcSEcCtD
Nedocromil—Urticaria—Methamphetamine—obesity	0.00223	0.00779	CcSEcCtD
Nedocromil—Urticaria—Benzphetamine—obesity	0.00215	0.00752	CcSEcCtD
Nedocromil—Ear pain—Sibutramine—obesity	0.00213	0.00743	CcSEcCtD
Nedocromil—Chest pain—Phentermine—obesity	0.0021	0.00735	CcSEcCtD
Nedocromil—Eczema—Orlistat—obesity	0.00209	0.00729	CcSEcCtD
Nedocromil—Hypersensitivity—Methamphetamine—obesity	0.00207	0.00723	CcSEcCtD
Nedocromil—Dry mouth—Phentermine—obesity	0.00206	0.00719	CcSEcCtD
Nedocromil—Gastroenteritis—Sibutramine—obesity	0.00205	0.00716	CcSEcCtD
Nedocromil—Photophobia—Bupropion—obesity	0.00205	0.00715	CcSEcCtD
Nedocromil—Eczema—Sibutramine—obesity	0.00202	0.00706	CcSEcCtD
Nedocromil—Tremor—Diethylpropion—obesity	0.00201	0.00704	CcSEcCtD
Nedocromil—Hypersensitivity—Benzphetamine—obesity	0.00199	0.00697	CcSEcCtD
Nedocromil—Nasal congestion—Sibutramine—obesity	0.00199	0.00696	CcSEcCtD
Nedocromil—Abdominal pain—Phendimetrazine—obesity	0.00195	0.00682	CcSEcCtD
Nedocromil—Arthritis—Orlistat—obesity	0.00193	0.00674	CcSEcCtD
Nedocromil—Leukopenia—Diethylpropion—obesity	0.00192	0.00673	CcSEcCtD
Nedocromil—Diarrhoea—Methamphetamine—obesity	0.00192	0.00671	CcSEcCtD
Nedocromil—Dyspnoea—Phenylpropanolamine—obesity	0.00188	0.00657	CcSEcCtD
Nedocromil—Arthritis—Sibutramine—obesity	0.00187	0.00653	CcSEcCtD
Nedocromil—Dizziness—Methamphetamine—obesity	0.00186	0.00649	CcSEcCtD
Nedocromil—Ear pain—Bupropion—obesity	0.00185	0.00648	CcSEcCtD
Nedocromil—Diarrhoea—Benzphetamine—obesity	0.00185	0.00647	CcSEcCtD
Nedocromil—Leukopenia—Cimetidine—obesity	0.00183	0.0064	CcSEcCtD
Nedocromil—Chest pain—Diethylpropion—obesity	0.00183	0.0064	CcSEcCtD
Nedocromil—Rash erythematous—Topiramate—obesity	0.00181	0.00634	CcSEcCtD
Nedocromil—Dizziness—Benzphetamine—obesity	0.00179	0.00626	CcSEcCtD
Nedocromil—Dry mouth—Diethylpropion—obesity	0.00179	0.00626	CcSEcCtD
Nedocromil—Gastroenteritis—Bupropion—obesity	0.00179	0.00624	CcSEcCtD
Nedocromil—Otitis media—Topiramate—obesity	0.00178	0.00623	CcSEcCtD
Nedocromil—Dyspepsia—Phentermine—obesity	0.00178	0.0062	CcSEcCtD
Nedocromil—Eczema—Bupropion—obesity	0.00176	0.00615	CcSEcCtD
Nedocromil—Headache—Methamphetamine—obesity	0.00176	0.00615	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Phentermine—obesity	0.00174	0.00609	CcSEcCtD
Nedocromil—Fatigue—Phentermine—obesity	0.00174	0.00608	CcSEcCtD
Nedocromil—Nasal congestion—Bupropion—obesity	0.00174	0.00607	CcSEcCtD
Nedocromil—Headache—Benzphetamine—obesity	0.0017	0.00593	CcSEcCtD
Nedocromil—Diarrhoea—Phendimetrazine—obesity	0.00169	0.0059	CcSEcCtD
Nedocromil—Dysphonia—Topiramate—obesity	0.00169	0.0059	CcSEcCtD
Nedocromil—Anaphylactic shock—Cimetidine—obesity	0.00167	0.00583	CcSEcCtD
Nedocromil—Dizziness—Phendimetrazine—obesity	0.00163	0.0057	CcSEcCtD
Nedocromil—Arthritis—Bupropion—obesity	0.00163	0.00569	CcSEcCtD
Nedocromil—Influenza—Orlistat—obesity	0.00162	0.00566	CcSEcCtD
Nedocromil—Nausea—Benzphetamine—obesity	0.00161	0.00562	CcSEcCtD
Nedocromil—Urticaria—Phentermine—obesity	0.0016	0.0056	CcSEcCtD
Nedocromil—Abdominal pain—Phentermine—obesity	0.00159	0.00557	CcSEcCtD
Nedocromil—Influenza—Sibutramine—obesity	0.00157	0.00548	CcSEcCtD
Nedocromil—Dyspnoea—Diethylpropion—obesity	0.00156	0.00547	CcSEcCtD
Nedocromil—Eosinophilia—Sibutramine—obesity	0.00155	0.00543	CcSEcCtD
Nedocromil—Hypersensitivity—Phenylpropanolamine—obesity	0.00155	0.00543	CcSEcCtD
Nedocromil—Headache—Phendimetrazine—obesity	0.00155	0.0054	CcSEcCtD
Nedocromil—Dyspepsia—Diethylpropion—obesity	0.00154	0.0054	CcSEcCtD
Nedocromil—Viral infection—Topiramate—obesity	0.00154	0.00537	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Diethylpropion—obesity	0.00152	0.00529	CcSEcCtD
Nedocromil—Bronchitis—Sibutramine—obesity	0.00151	0.00527	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Orlistat—obesity	0.00151	0.00526	CcSEcCtD
Nedocromil—Nausea—Phendimetrazine—obesity	0.00147	0.00512	CcSEcCtD
Nedocromil—Asthenia—Phentermine—obesity	0.00145	0.00506	CcSEcCtD
Nedocromil—Fatigue—Cimetidine—obesity	0.00144	0.00503	CcSEcCtD
Nedocromil—Pneumonia—Sibutramine—obesity	0.00141	0.00492	CcSEcCtD
Nedocromil—Urticaria—Diethylpropion—obesity	0.00139	0.00487	CcSEcCtD
Nedocromil—Dizziness—Phenylpropanolamine—obesity	0.00139	0.00487	CcSEcCtD
Nedocromil—Diarrhoea—Phentermine—obesity	0.00138	0.00482	CcSEcCtD
Nedocromil—Influenza—Bupropion—obesity	0.00137	0.00478	CcSEcCtD
Nedocromil—Conjunctivitis—Sibutramine—obesity	0.00136	0.00475	CcSEcCtD
Nedocromil—Sinusitis—Orlistat—obesity	0.00136	0.00474	CcSEcCtD
Nedocromil—Vomiting—Phenylpropanolamine—obesity	0.00134	0.00468	CcSEcCtD
Nedocromil—Dizziness—Phentermine—obesity	0.00133	0.00466	CcSEcCtD
Nedocromil—Rash—Phenylpropanolamine—obesity	0.00133	0.00464	CcSEcCtD
Nedocromil—Dermatitis—Phenylpropanolamine—obesity	0.00133	0.00464	CcSEcCtD
Nedocromil—Body temperature increased—Cimetidine—obesity	0.00132	0.00461	CcSEcCtD
Nedocromil—Bronchitis—Bupropion—obesity	0.00132	0.0046	CcSEcCtD
Nedocromil—Sinusitis—Sibutramine—obesity	0.00131	0.00459	CcSEcCtD
Nedocromil—Photophobia—Topiramate—obesity	0.0013	0.00456	CcSEcCtD
Nedocromil—Pharyngitis—Orlistat—obesity	0.00129	0.0045	CcSEcCtD
Nedocromil—Vomiting—Phentermine—obesity	0.00128	0.00448	CcSEcCtD
Nedocromil—Rash—Phentermine—obesity	0.00127	0.00444	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Bupropion—obesity	0.00127	0.00444	CcSEcCtD
Nedocromil—Dermatitis—Phentermine—obesity	0.00127	0.00444	CcSEcCtD
Nedocromil—Headache—Phentermine—obesity	0.00126	0.00442	CcSEcCtD
Nedocromil—Rhinitis—Sibutramine—obesity	0.00126	0.0044	CcSEcCtD
Nedocromil—Nausea—Phenylpropanolamine—obesity	0.00125	0.00438	CcSEcCtD
Nedocromil—Pharyngitis—Sibutramine—obesity	0.00125	0.00435	CcSEcCtD
Nedocromil—Hypersensitivity—Cimetidine—obesity	0.00123	0.0043	CcSEcCtD
Nedocromil—Pneumonia—Bupropion—obesity	0.00123	0.00429	CcSEcCtD
Nedocromil—Visual impairment—Sibutramine—obesity	0.00121	0.00423	CcSEcCtD
Nedocromil—Diarrhoea—Diethylpropion—obesity	0.0012	0.0042	CcSEcCtD
Nedocromil—Nausea—Phentermine—obesity	0.0012	0.00419	CcSEcCtD
Nedocromil—Asthenia—Cimetidine—obesity	0.0012	0.00419	CcSEcCtD
Nedocromil—Conjunctivitis—Bupropion—obesity	0.00119	0.00414	CcSEcCtD
Nedocromil—Ear pain—Topiramate—obesity	0.00118	0.00413	CcSEcCtD
Nedocromil—Dizziness—Diethylpropion—obesity	0.00116	0.00405	CcSEcCtD
Nedocromil—Sinusitis—Bupropion—obesity	0.00114	0.004	CcSEcCtD
Nedocromil—Diarrhoea—Cimetidine—obesity	0.00114	0.00399	CcSEcCtD
Nedocromil—Gastroenteritis—Topiramate—obesity	0.00114	0.00397	CcSEcCtD
Nedocromil—Eczema—Topiramate—obesity	0.00112	0.00392	CcSEcCtD
Nedocromil—Vomiting—Diethylpropion—obesity	0.00112	0.0039	CcSEcCtD
Nedocromil—Nasal congestion—Topiramate—obesity	0.00111	0.00387	CcSEcCtD
Nedocromil—Rash—Diethylpropion—obesity	0.00111	0.00387	CcSEcCtD
Nedocromil—Dysgeusia—Orlistat—obesity	0.00111	0.00386	CcSEcCtD
Nedocromil—Dermatitis—Diethylpropion—obesity	0.00111	0.00386	CcSEcCtD
Nedocromil—Dizziness—Cimetidine—obesity	0.0011	0.00386	CcSEcCtD
Nedocromil—Headache—Diethylpropion—obesity	0.0011	0.00384	CcSEcCtD
Nedocromil—Rhinitis—Bupropion—obesity	0.0011	0.00383	CcSEcCtD
Nedocromil—Pharyngitis—Bupropion—obesity	0.00109	0.0038	CcSEcCtD
Nedocromil—Dysgeusia—Sibutramine—obesity	0.00107	0.00374	CcSEcCtD
Nedocromil—Vomiting—Cimetidine—obesity	0.00106	0.00371	CcSEcCtD
Nedocromil—Visual impairment—Bupropion—obesity	0.00106	0.00369	CcSEcCtD
Nedocromil—Rash—Cimetidine—obesity	0.00105	0.00368	CcSEcCtD
Nedocromil—Dermatitis—Cimetidine—obesity	0.00105	0.00368	CcSEcCtD
Nedocromil—Headache—Cimetidine—obesity	0.00105	0.00366	CcSEcCtD
Nedocromil—Nausea—Diethylpropion—obesity	0.00104	0.00364	CcSEcCtD
Nedocromil—Tremor—Sibutramine—obesity	0.00102	0.00358	CcSEcCtD
Nedocromil—Nausea—Cimetidine—obesity	0.000992	0.00347	CcSEcCtD
Nedocromil—Cough—Orlistat—obesity	0.000986	0.00344	CcSEcCtD
Nedocromil—Leukopenia—Sibutramine—obesity	0.000979	0.00342	CcSEcCtD
Nedocromil—Chest pain—Orlistat—obesity	0.000962	0.00336	CcSEcCtD
Nedocromil—Cough—Sibutramine—obesity	0.000954	0.00333	CcSEcCtD
Nedocromil—Dry mouth—Orlistat—obesity	0.000941	0.00329	CcSEcCtD
Nedocromil—Dysgeusia—Bupropion—obesity	0.000933	0.00326	CcSEcCtD
Nedocromil—Chest pain—Sibutramine—obesity	0.000931	0.00325	CcSEcCtD
Nedocromil—Anaphylactic shock—Orlistat—obesity	0.000922	0.00322	CcSEcCtD
Nedocromil—Dry mouth—Sibutramine—obesity	0.00091	0.00318	CcSEcCtD
Nedocromil—Tremor—Bupropion—obesity	0.000893	0.00312	CcSEcCtD
Nedocromil—Anaphylactic shock—Sibutramine—obesity	0.000892	0.00312	CcSEcCtD
Nedocromil—Eosinophilia—Topiramate—obesity	0.000863	0.00301	CcSEcCtD
Nedocromil—Leukopenia—Bupropion—obesity	0.000853	0.00298	CcSEcCtD
Nedocromil—Bronchitis—Topiramate—obesity	0.000838	0.00293	CcSEcCtD
Nedocromil—Cough—Bupropion—obesity	0.000832	0.00291	CcSEcCtD
Nedocromil—Dyspepsia—Orlistat—obesity	0.000811	0.00284	CcSEcCtD
Nedocromil—Chest pain—Bupropion—obesity	0.000811	0.00283	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Topiramate—obesity	0.00081	0.00283	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Orlistat—obesity	0.000796	0.00278	CcSEcCtD
Nedocromil—Dyspnoea—Sibutramine—obesity	0.000795	0.00278	CcSEcCtD
Nedocromil—Fatigue—Orlistat—obesity	0.000795	0.00278	CcSEcCtD
Nedocromil—Dry mouth—Bupropion—obesity	0.000794	0.00277	CcSEcCtD
Nedocromil—Pain—Orlistat—obesity	0.000788	0.00275	CcSEcCtD
Nedocromil—Dyspepsia—Sibutramine—obesity	0.000785	0.00274	CcSEcCtD
Nedocromil—Pneumonia—Topiramate—obesity	0.000781	0.00273	CcSEcCtD
Nedocromil—Anaphylactic shock—Bupropion—obesity	0.000778	0.00272	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Sibutramine—obesity	0.00077	0.00269	CcSEcCtD
Nedocromil—Pain—Sibutramine—obesity	0.000763	0.00267	CcSEcCtD
Nedocromil—Conjunctivitis—Topiramate—obesity	0.000755	0.00264	CcSEcCtD
Nedocromil—Gastrointestinal pain—Orlistat—obesity	0.000754	0.00263	CcSEcCtD
Nedocromil—Urticaria—Orlistat—obesity	0.000732	0.00256	CcSEcCtD
Nedocromil—Gastrointestinal pain—Sibutramine—obesity	0.00073	0.00255	CcSEcCtD
Nedocromil—Sinusitis—Topiramate—obesity	0.000729	0.00255	CcSEcCtD
Nedocromil—Abdominal pain—Orlistat—obesity	0.000729	0.00255	CcSEcCtD
Nedocromil—Body temperature increased—Orlistat—obesity	0.000729	0.00255	CcSEcCtD
Nedocromil—Urticaria—Sibutramine—obesity	0.000709	0.00248	CcSEcCtD
Nedocromil—Body temperature increased—Sibutramine—obesity	0.000705	0.00246	CcSEcCtD
Nedocromil—Abdominal pain—Sibutramine—obesity	0.000705	0.00246	CcSEcCtD
Nedocromil—Rhinitis—Topiramate—obesity	0.000699	0.00244	CcSEcCtD
Nedocromil—Dyspnoea—Bupropion—obesity	0.000693	0.00242	CcSEcCtD
Nedocromil—Pharyngitis—Topiramate—obesity	0.000692	0.00242	CcSEcCtD
Nedocromil—Dyspepsia—Bupropion—obesity	0.000685	0.00239	CcSEcCtD
Nedocromil—Hypersensitivity—Orlistat—obesity	0.000679	0.00237	CcSEcCtD
Nedocromil—Visual impairment—Topiramate—obesity	0.000672	0.00235	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Bupropion—obesity	0.000672	0.00235	CcSEcCtD
Nedocromil—Fatigue—Bupropion—obesity	0.000671	0.00234	CcSEcCtD
Nedocromil—Pain—Bupropion—obesity	0.000665	0.00232	CcSEcCtD
Nedocromil—Asthenia—Orlistat—obesity	0.000661	0.00231	CcSEcCtD
Nedocromil—Hypersensitivity—Sibutramine—obesity	0.000657	0.0023	CcSEcCtD
Nedocromil—Asthenia—Sibutramine—obesity	0.00064	0.00224	CcSEcCtD
Nedocromil—Gastrointestinal pain—Bupropion—obesity	0.000636	0.00222	CcSEcCtD
Nedocromil—Diarrhoea—Orlistat—obesity	0.000631	0.0022	CcSEcCtD
Nedocromil—Urticaria—Bupropion—obesity	0.000618	0.00216	CcSEcCtD
Nedocromil—Abdominal pain—Bupropion—obesity	0.000615	0.00215	CcSEcCtD
Nedocromil—Body temperature increased—Bupropion—obesity	0.000615	0.00215	CcSEcCtD
Nedocromil—Diarrhoea—Sibutramine—obesity	0.00061	0.00213	CcSEcCtD
Nedocromil—Dizziness—Orlistat—obesity	0.00061	0.00213	CcSEcCtD
Nedocromil—Dysgeusia—Topiramate—obesity	0.000595	0.00208	CcSEcCtD
Nedocromil—Dizziness—Sibutramine—obesity	0.00059	0.00206	CcSEcCtD
Nedocromil—Vomiting—Orlistat—obesity	0.000586	0.00205	CcSEcCtD
Nedocromil—Rash—Orlistat—obesity	0.000581	0.00203	CcSEcCtD
Nedocromil—Dermatitis—Orlistat—obesity	0.000581	0.00203	CcSEcCtD
Nedocromil—Headache—Orlistat—obesity	0.000578	0.00202	CcSEcCtD
Nedocromil—Hypersensitivity—Bupropion—obesity	0.000573	0.002	CcSEcCtD
Nedocromil—Tremor—Topiramate—obesity	0.000569	0.00199	CcSEcCtD
Nedocromil—Vomiting—Sibutramine—obesity	0.000567	0.00198	CcSEcCtD
Nedocromil—Rash—Sibutramine—obesity	0.000563	0.00197	CcSEcCtD
Nedocromil—Dermatitis—Sibutramine—obesity	0.000562	0.00196	CcSEcCtD
Nedocromil—Headache—Sibutramine—obesity	0.000559	0.00195	CcSEcCtD
Nedocromil—Asthenia—Bupropion—obesity	0.000558	0.00195	CcSEcCtD
Nedocromil—Nausea—Orlistat—obesity	0.000548	0.00191	CcSEcCtD
Nedocromil—Leukopenia—Topiramate—obesity	0.000543	0.0019	CcSEcCtD
Nedocromil—Diarrhoea—Bupropion—obesity	0.000532	0.00186	CcSEcCtD
Nedocromil—Nausea—Sibutramine—obesity	0.00053	0.00185	CcSEcCtD
Nedocromil—Cough—Topiramate—obesity	0.00053	0.00185	CcSEcCtD
Nedocromil—Chest pain—Topiramate—obesity	0.000517	0.00181	CcSEcCtD
Nedocromil—Dizziness—Bupropion—obesity	0.000514	0.0018	CcSEcCtD
Nedocromil—Dry mouth—Topiramate—obesity	0.000506	0.00177	CcSEcCtD
Nedocromil—Vomiting—Bupropion—obesity	0.000495	0.00173	CcSEcCtD
Nedocromil—Rash—Bupropion—obesity	0.00049	0.00171	CcSEcCtD
Nedocromil—Dermatitis—Bupropion—obesity	0.00049	0.00171	CcSEcCtD
Nedocromil—Headache—Bupropion—obesity	0.000487	0.0017	CcSEcCtD
Nedocromil—Nausea—Bupropion—obesity	0.000462	0.00161	CcSEcCtD
Nedocromil—Dyspnoea—Topiramate—obesity	0.000442	0.00154	CcSEcCtD
Nedocromil—Dyspepsia—Topiramate—obesity	0.000436	0.00152	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Topiramate—obesity	0.000428	0.00149	CcSEcCtD
Nedocromil—Fatigue—Topiramate—obesity	0.000427	0.00149	CcSEcCtD
Nedocromil—Pain—Topiramate—obesity	0.000424	0.00148	CcSEcCtD
Nedocromil—Gastrointestinal pain—Topiramate—obesity	0.000405	0.00142	CcSEcCtD
Nedocromil—Urticaria—Topiramate—obesity	0.000394	0.00138	CcSEcCtD
Nedocromil—Body temperature increased—Topiramate—obesity	0.000392	0.00137	CcSEcCtD
Nedocromil—Abdominal pain—Topiramate—obesity	0.000392	0.00137	CcSEcCtD
Nedocromil—Hypersensitivity—Topiramate—obesity	0.000365	0.00128	CcSEcCtD
Nedocromil—Asthenia—Topiramate—obesity	0.000356	0.00124	CcSEcCtD
Nedocromil—Diarrhoea—Topiramate—obesity	0.000339	0.00118	CcSEcCtD
Nedocromil—Dizziness—Topiramate—obesity	0.000328	0.00114	CcSEcCtD
Nedocromil—Vomiting—Topiramate—obesity	0.000315	0.0011	CcSEcCtD
Nedocromil—Rash—Topiramate—obesity	0.000312	0.00109	CcSEcCtD
Nedocromil—Dermatitis—Topiramate—obesity	0.000312	0.00109	CcSEcCtD
Nedocromil—Headache—Topiramate—obesity	0.00031	0.00108	CcSEcCtD
Nedocromil—Nausea—Topiramate—obesity	0.000294	0.00103	CcSEcCtD
Nedocromil—HSP90AA1—Signaling Pathways—DRD1—obesity	2.97e-05	5.65e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CD36—obesity	2.97e-05	5.65e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—APOB—obesity	2.95e-05	5.61e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—NCOA1—obesity	2.94e-05	5.59e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—POMC—obesity	2.92e-05	5.56e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—INS—obesity	2.91e-05	5.53e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—STK11—obesity	2.89e-05	5.51e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CYP19A1—obesity	2.89e-05	5.51e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NTRK2—obesity	2.89e-05	5.5e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—LPL—obesity	2.88e-05	5.49e-05	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—AKT1—obesity	2.88e-05	5.49e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PRKCD—obesity	2.88e-05	5.48e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCL5—obesity	2.88e-05	5.48e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ADRB1—obesity	2.88e-05	5.47e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—FOXO1—obesity	2.86e-05	5.45e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CCL2—obesity	2.86e-05	5.44e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—IL6—obesity	2.84e-05	5.4e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—GHRL—obesity	2.81e-05	5.36e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PARP1—obesity	2.81e-05	5.36e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—LPL—obesity	2.81e-05	5.36e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—C3—obesity	2.81e-05	5.35e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IGF1—obesity	2.81e-05	5.35e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—AKT2—obesity	2.81e-05	5.35e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—FOXO1—obesity	2.79e-05	5.32e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—DRD4—obesity	2.79e-05	5.31e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—RPS6KB1—obesity	2.79e-05	5.31e-05	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—AKT1—obesity	2.78e-05	5.3e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—PIK3CB—obesity	2.76e-05	5.26e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—IL6—obesity	2.74e-05	5.22e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—STAT3—obesity	2.72e-05	5.18e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PIK3CD—obesity	2.7e-05	5.14e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MMP9—obesity	2.7e-05	5.14e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—COMT—obesity	2.69e-05	5.12e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IRS2—obesity	2.68e-05	5.09e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CRP—obesity	2.68e-05	5.09e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—PIK3CA—obesity	2.67e-05	5.09e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—SERPINE1—obesity	2.67e-05	5.08e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CNR1—obesity	2.67e-05	5.07e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—IL6—obesity	2.66e-05	5.07e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PRKCD—obesity	2.66e-05	5.06e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GNB3—obesity	2.65e-05	5.05e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PPARGC1A—obesity	2.65e-05	5.05e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—HMOX1—obesity	2.64e-05	5.03e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—MAPK8—obesity	2.63e-05	5e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MAPK8—obesity	2.63e-05	5e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TCF7L2—obesity	2.62e-05	4.98e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—AKT1—obesity	2.62e-05	4.98e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—MYC—obesity	2.62e-05	4.98e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MMP9—obesity	2.61e-05	4.96e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—DRD2—obesity	2.6e-05	4.95e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TYK2—obesity	2.6e-05	4.94e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MTHFR—obesity	2.6e-05	4.94e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PRKCD—obesity	2.59e-05	4.93e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GNAS—obesity	2.58e-05	4.92e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—RHOA—obesity	2.58e-05	4.9e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—GCG—obesity	2.57e-05	4.9e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PTPN1—obesity	2.57e-05	4.9e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—TLR4—obesity	2.57e-05	4.88e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PIK3R1—obesity	2.55e-05	4.85e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—NOS3—obesity	2.55e-05	4.85e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HTR2A—obesity	2.54e-05	4.83e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MAPK8—obesity	2.54e-05	4.82e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—C3—obesity	2.53e-05	4.82e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—APOB—obesity	2.53e-05	4.81e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—AKT1—obesity	2.53e-05	4.81e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—TGFB1—obesity	2.52e-05	4.8e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—IRS2—obesity	2.47e-05	4.7e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PRKCB—obesity	2.47e-05	4.7e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—ICAM1—obesity	2.46e-05	4.68e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PRL—obesity	2.46e-05	4.67e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—BAD—obesity	2.44e-05	4.64e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—PIK3CA—obesity	2.43e-05	4.62e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—STK11—obesity	2.42e-05	4.61e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—APOE—obesity	2.42e-05	4.6e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—LPL—obesity	2.42e-05	4.6e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IRS2—obesity	2.41e-05	4.59e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—AGT—obesity	2.41e-05	4.58e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—STAT3—obesity	2.4e-05	4.57e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CAV1—obesity	2.4e-05	4.56e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PLG—obesity	2.39e-05	4.55e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—APOA1—obesity	2.39e-05	4.55e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—LEP—obesity	2.36e-05	4.49e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—APOE—obesity	2.36e-05	4.49e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GPX1—obesity	2.36e-05	4.49e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—TNF—obesity	2.36e-05	4.48e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PIK3CB—obesity	2.35e-05	4.48e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MTOR—obesity	2.35e-05	4.48e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—MYC—obesity	2.34e-05	4.45e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CAV1—obesity	2.34e-05	4.45e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IRS1—obesity	2.34e-05	4.45e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—FOXO3—obesity	2.34e-05	4.45e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—APOA1—obesity	2.33e-05	4.44e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ADRB2—obesity	2.33e-05	4.43e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—STAT3—obesity	2.32e-05	4.41e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CD36—obesity	2.3e-05	4.37e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SOCS1—obesity	2.29e-05	4.37e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SOCS3—obesity	2.27e-05	4.31e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—BAD—obesity	2.25e-05	4.29e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—ESR1—obesity	2.25e-05	4.29e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MYC—obesity	2.23e-05	4.24e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—F2—obesity	2.22e-05	4.23e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PRKCB—obesity	2.22e-05	4.23e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TGFB1—obesity	2.22e-05	4.23e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—GNB3—obesity	2.22e-05	4.22e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—BAD—obesity	2.2e-05	4.18e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—AKT1—obesity	2.18e-05	4.16e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IGF2—obesity	2.18e-05	4.15e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—MTHFR—obesity	2.18e-05	4.14e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—AKT2—obesity	2.16e-05	4.12e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—GNAS—obesity	2.16e-05	4.11e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—IRS1—obesity	2.16e-05	4.1e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MYC—obesity	2.15e-05	4.1e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—IL6—obesity	2.15e-05	4.09e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TGFB1—obesity	2.15e-05	4.09e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PPARA—obesity	2.13e-05	4.06e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PIK3CG—obesity	2.13e-05	4.05e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—APOB—obesity	2.12e-05	4.03e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IRS1—obesity	2.1e-05	4e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PIK3CD—obesity	2.08e-05	3.95e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—AGT—obesity	2.07e-05	3.93e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCL5—obesity	2.07e-05	3.93e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—INS—obesity	2.07e-05	3.93e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MMP9—obesity	2.05e-05	3.89e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—POMC—obesity	2.03e-05	3.86e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—APOE—obesity	2.03e-05	3.85e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—LPL—obesity	2.02e-05	3.84e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—INS—obesity	2.02e-05	3.84e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CAV1—obesity	2.01e-05	3.82e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—FOXO1—obesity	2.01e-05	3.82e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—RPS6KB1—obesity	2e-05	3.81e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—APOA1—obesity	2e-05	3.81e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—TYK2—obesity	2e-05	3.8e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—AKT2—obesity	2e-05	3.8e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MAPK8—obesity	1.99e-05	3.79e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—AKT1—obesity	1.98e-05	3.78e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCL2—obesity	1.98e-05	3.77e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PIK3R1—obesity	1.96e-05	3.73e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IGF1—obesity	1.95e-05	3.71e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—AKT2—obesity	1.95e-05	3.71e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PIK3CD—obesity	1.92e-05	3.65e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—IL6—obesity	1.9e-05	3.62e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—SERPINE1—obesity	1.9e-05	3.61e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—PIK3CA—obesity	1.9e-05	3.61e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—PIK3CA—obesity	1.89e-05	3.6e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—BCL2—obesity	1.89e-05	3.59e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IFNG—obesity	1.87e-05	3.56e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PIK3CD—obesity	1.87e-05	3.56e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PRKCD—obesity	1.86e-05	3.54e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—PIK3CA—obesity	1.85e-05	3.53e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—SERPINE1—obesity	1.85e-05	3.52e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—TYK2—obesity	1.85e-05	3.51e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—RHOA—obesity	1.83e-05	3.48e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—PIK3CA—obesity	1.83e-05	3.48e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PIK3CG—obesity	1.83e-05	3.48e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HTR2A—obesity	1.82e-05	3.47e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—C3—obesity	1.82e-05	3.46e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—STAT3—obesity	1.82e-05	3.46e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PIK3R1—obesity	1.81e-05	3.45e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—NOS3—obesity	1.81e-05	3.45e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—MTOR—obesity	1.81e-05	3.45e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PIK3CB—obesity	1.81e-05	3.45e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TYK2—obesity	1.8e-05	3.43e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—RHOA—obesity	1.79e-05	3.4e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PIK3R1—obesity	1.77e-05	3.36e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NOS3—obesity	1.77e-05	3.36e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PPARG—obesity	1.76e-05	3.36e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—AKT1—obesity	1.75e-05	3.34e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—POMC—obesity	1.74e-05	3.31e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IRS2—obesity	1.73e-05	3.29e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—INS—obesity	1.73e-05	3.29e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—AGT—obesity	1.73e-05	3.29e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—APOE—obesity	1.69e-05	3.22e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—LEP—obesity	1.69e-05	3.22e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MYC—obesity	1.69e-05	3.22e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TGFB1—obesity	1.69e-05	3.21e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—PIK3CA—obesity	1.68e-05	3.2e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—IL6—obesity	1.68e-05	3.19e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CAV1—obesity	1.68e-05	3.19e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—IL6—obesity	1.68e-05	3.19e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—APOA1—obesity	1.67e-05	3.19e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PIK3CB—obesity	1.67e-05	3.18e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MTOR—obesity	1.67e-05	3.18e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL1B—obesity	1.67e-05	3.18e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PTGS2—obesity	1.66e-05	3.15e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MTOR—obesity	1.63e-05	3.1e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PIK3CB—obesity	1.63e-05	3.1e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IL6—obesity	1.62e-05	3.08e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ESR1—obesity	1.62e-05	3.08e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PIK3CD—obesity	1.61e-05	3.06e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—F2—obesity	1.6e-05	3.04e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PRKCB—obesity	1.6e-05	3.04e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ALB—obesity	1.59e-05	3.02e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—BAD—obesity	1.58e-05	3e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—AKT1—obesity	1.55e-05	2.95e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—AKT1—obesity	1.55e-05	2.94e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—MAPK8—obesity	1.53e-05	2.91e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PIK3CG—obesity	1.53e-05	2.91e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—NOS3—obesity	1.52e-05	2.89e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PIK3R1—obesity	1.52e-05	2.89e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—AKT1—obesity	1.51e-05	2.88e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IRS1—obesity	1.51e-05	2.87e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—AKT1—obesity	1.49e-05	2.84e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—IL6—obesity	1.49e-05	2.84e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—POMC—obesity	1.45e-05	2.77e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—INS—obesity	1.45e-05	2.75e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PIK3CA—obesity	1.43e-05	2.73e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCL2—obesity	1.42e-05	2.71e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MMP9—obesity	1.42e-05	2.7e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PIK3CB—obesity	1.4e-05	2.66e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—STAT3—obesity	1.4e-05	2.66e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IGF1—obesity	1.4e-05	2.66e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—AKT2—obesity	1.4e-05	2.66e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PTGS2—obesity	1.39e-05	2.64e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MAPK8—obesity	1.38e-05	2.62e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—AKT1—obesity	1.38e-05	2.62e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PIK3CD—obesity	1.34e-05	2.56e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SERPINE1—obesity	1.33e-05	2.53e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TYK2—obesity	1.29e-05	2.46e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—STAT3—obesity	1.29e-05	2.46e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—RHOA—obesity	1.28e-05	2.44e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IL6—obesity	1.27e-05	2.42e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PIK3R1—obesity	1.27e-05	2.41e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NOS3—obesity	1.27e-05	2.41e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—STAT3—obesity	1.26e-05	2.4e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MYC—obesity	1.2e-05	2.29e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—TGFB1—obesity	1.2e-05	2.28e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—AKT1—obesity	1.17e-05	2.23e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MYC—obesity	1.17e-05	2.23e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MTOR—obesity	1.17e-05	2.23e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PIK3CB—obesity	1.17e-05	2.23e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TGFB1—obesity	1.17e-05	2.22e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PIK3CA—obesity	1.1e-05	2.1e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PIK3CA—obesity	1.02e-05	1.94e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MMP9—obesity	1.02e-05	1.94e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PIK3CA—obesity	9.94e-06	1.89e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MAPK8—obesity	9.9e-06	1.88e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL6—obesity	9.78e-06	1.86e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—STAT3—obesity	9.05e-06	1.72e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—IL6—obesity	9.03e-06	1.72e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—AKT1—obesity	9.02e-06	1.72e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IL6—obesity	8.81e-06	1.68e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PIK3CA—obesity	8.54e-06	1.62e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MYC—obesity	8.41e-06	1.6e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TGFB1—obesity	8.39e-06	1.6e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—AKT1—obesity	8.33e-06	1.58e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—AKT1—obesity	8.12e-06	1.55e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PIK3CA—obesity	7.14e-06	1.36e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—AKT1—obesity	6.97e-06	1.33e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IL6—obesity	6.32e-06	1.2e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—AKT1—obesity	5.83e-06	1.11e-05	CbGpPWpGaD
